{"podcast":{"title":"The BioHub - by Avetix","slug":"the-biohub-by-avetix-7252289","podcast_index_feed_id":7252289,"rss_url":"https://anchor.fm/s/f0076084/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/max-brennan4","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1775724702970-e7a36a5e3cf58.jpg","author":"Max Brennan - Biotech HeadHunter","episode_count":230,"summary":"Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.","last_synced_at":"2026-07-21T04:19:24.893516+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289"},"episode":{"title":"Episode 158 - Daniel Hader - Model Medicines","slug":"episode-158-daniel-hader-model-medicines","published_at":"2026-04-22T08:40:19+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-158-daniel-hader-model-medicines","show_page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289","url":"https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-158---Daniel-Hader---Model-Medicines-e3i8lm8","audio_url":"https://anchor.fm/s/f0076084/podcast/play/118822024/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-22%2F422591580-44100-2-42cc3965d02cc.mp3","summary":"In this episode of the BioHub Podcast, Amber is joined by Daniel, Co-Founder and CEO of Model Medicines. Model Medicines is building an AI-driven drug discovery platform with a fundamentally different approach, focusing on applying machine learning to problems where traditional methods have failed. Daniel shares how the team is targeting biological “choke points” across multiple diseases, why throughput and inference may matter more than model size, and how they’re thinking about scaling into development as programmes move towards the clinic.","meta_description":"In this episode of the BioHub Podcast, Amber is joined by Daniel, Co-Founder and CEO of Model Medicines. Model Medicines is building an AI-driven drug dis…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2711,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-158-daniel-hader-model-medicines/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-158-daniel-hader-model-medicines.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}